[Ip-health] J Barton on Access + Innovation Tonight

[Sean Flynn]

This is a multi-part message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
Achieving Innovation + Access in Global Pharmaceutical Markets



A Discussion with Professor John Barton

Stanford University School of Law



With Responses by

Brook Baker, Northeastern University

Joseph Damond, Pfizer

Sean Flynn, American University Washington College of Law

James Love, Knowledge Ecology International

Rohit Malpani, Oxfam Int'l

Sharon Treat, National Legislative Association on Prescription Drug

Prices

Robert Weissman, Essential Action



Sponsored by

American University Washington College of Law Program on Information

Justice and Intellectual Property

Knowledge Ecology International

Forum on Democracy and Trade



7pm on Thursday, February 19.

Washington College of Law, located at 4801 Massachusetts Ave., NW

Room 608 (6th floor lounge)



Reception from 7pm

Event begins 7:15pm



Registration

http://www.wcl.american.edu/secle/cle_form.cfm



Webcast (live with questions and on demand):

www.wcl.american.edu/pijip/webcast.cfm



Professor John Barton, the former Chair of the UK Commission on

Intellectual Property Rights, and Pfizer CEO Jeff Kindler recently

outlined a proposed global framework on medicine pricing to protect

research and development incentives while promoting greater access to

drugs in low and middle income countries. The proposal calls for trade

agreement measures to restrain developed countries from excessive use of

price controls while promoting price discrimination in middle income

countries so that the richer segments of the population will pay more

than poorer segments. Meanwhile, many global access to medicines

campaigners and developing countries have been advocating for a new

research and development framework that would delink the price of the

product from the incentive to produce new medicines, e.g. through

various proposals for prize funds, direct government funding of research

and development other means while promoting full competition for the

supply of needed products.

On PIJIP and KEI are pleased to announce that Professor Barton will

further explain and discuss his proposal at the Washington College of

Law on Thursday, February 19. Responders from civil society will comment

on the proposal and offer alternative models for the financing of

patent-driven research for health in middle and low income nations.